Counterpoint Mutual Funds’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$742K Sell
24,892
-4,354
-15% -$130K 0.09% 75
2024
Q3
$457K Buy
29,246
+17,605
+151% +$275K 0.09% 106
2024
Q2
$199K Sell
11,641
-36,005
-76% -$617K 0.05% 208
2024
Q1
$745K Buy
47,646
+19,489
+69% +$305K 0.18% 8
2023
Q4
$420K Buy
28,157
+20,686
+277% +$309K 0.16% 9
2023
Q3
$121K Buy
+7,471
New +$121K 0.1% 169